Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030 C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ... Journal of hepatology 69 (4), 896-904, 2018 | 1722 | 2018 |
Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography K Imajo, T Kessoku, Y Honda, W Tomeno, Y Ogawa, H Mawatari, K Fujita, ... Gastroenterology 150 (3), 626-637. e7, 2016 | 850 | 2016 |
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis Y Sumida, A Nakajima, Y Itoh World journal of gastroenterology: WJG 20 (2), 475, 2014 | 706 | 2014 |
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) M Yoneda, H Mawatari, K Fujita, H Endo, H Iida, Y Nozaki, K Yonemitsu, ... Digestive and Liver Disease 40 (5), 371-378, 2008 | 534 | 2008 |
FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis N Kobayashi, N Hiraoka, W Yamagami, H Ojima, Y Kanai, T Kosuge, ... Clinical Cancer Research 13 (3), 902-911, 2007 | 519 | 2007 |
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography M Yoneda, K Suzuki, S Kato, K Fujita, Y Nozaki, K Hosono, S Saito, ... Radiology 256 (2), 640-647, 2010 | 477 | 2010 |
Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial K Hosono, H Endo, H Takahashi, M Sugiyama, E Sakai, T Uchiyama, ... Cancer prevention research 3 (9), 1077-1083, 2010 | 406 | 2010 |
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH M Yoneda, H Mawatari, K Fujita, H Iida, K Yonemitsu, S Kato, ... Journal of gastroenterology 42, 573-582, 2007 | 387 | 2007 |
Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling K Imajo, K Fujita, M Yoneda, Y Nozaki, Y Ogawa, Y Shinohara, S Kato, ... Cell metabolism 16 (1), 44-54, 2012 | 379 | 2012 |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ... Gut 71 (5), 1006-1019, 2022 | 354 | 2022 |
Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants C Hsu, C Caussy, K Imajo, J Chen, S Singh, K Kaulback, MD Le, J Hooker, ... Clinical Gastroenterology and Hepatology 17 (4), 630-637. e8, 2019 | 349 | 2019 |
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis S Watanabe, E Hashimoto, K Ikejima, H Uto, M Ono, Y Sumida, M Seike, ... Journal of gastroenterology 50 (4), 364-377, 2015 | 349 | 2015 |
Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) M Yoneda, K Fujita, M Inamori, A Nakajima, M Tamano, H Hiraishi Gut 56 (9), 1330-1331, 2007 | 338 | 2007 |
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled … T Higurashi, K Hosono, H Takahashi, Y Komiya, S Umezawa, E Sakai, ... The Lancet Oncology 17 (4), 475-483, 2016 | 327 | 2016 |
Variations in the FTO gene are associated with severe obesity in the Japanese K Hotta, Y Nakata, T Matsuo, S Kamohara, K Kotani, R Komatsu, N Itoh, ... Journal of human genetics 53 (6), 546-553, 2008 | 327 | 2008 |
Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury A Nakajima, K Wada, H Miki, N Kubota, N Nakajima, Y Terauchi, ... Gastroenterology 120 (2), 460-469, 2001 | 322 | 2001 |
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease M Yoneda, S Naka, K Nakano, K Wada, H Endo, H Mawatari, K Imajo, ... BMC gastroenterology 12, 1-10, 2012 | 306 | 2012 |
Dysfunctional very‐low‐density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis K Fujita, Y Nozaki, K Wada, M Yoneda, Y Fujimoto, M Fujitake, H Endo, ... Hepatology 50 (3), 772-780, 2009 | 293 | 2009 |
Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice E Osawa, A Nakajima, K Wada, S Ishimine, N Fujisawa, T Kawamori, ... Gastroenterology 124 (2), 361-367, 2003 | 285 | 2003 |
Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity Y Komiya, Y Shimomura, T Higurashi, Y Sugi, J Arimoto, S Umezawa, ... Gut 68 (7), 1335-1337, 2019 | 250 | 2019 |